These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27847992)

  • 1. [ESC guidelines on atrial fibrillation 2016 : Summary of the most relevant recommendations and modifications].
    Eckardt L; Häusler KG; Ravens U; Borggrefe M; Kirchhof P
    Herz; 2016 Dec; 41(8):677-683. PubMed ID: 27847992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.
    Hindricks G; Potpara T; Dagres N; Arbelo E; Bax JJ; Blomström-Lundqvist C; Boriani G; Castella M; Dan GA; Dilaveris PE; Fauchier L; Filippatos G; Kalman JM; La Meir M; Lane DA; Lebeau JP; Lettino M; Lip GYH; Pinto FJ; Thomas GN; Valgimigli M; Van Gelder IC; Van Putte BP; Watkins CL;
    Eur Heart J; 2021 Feb; 42(5):373-498. PubMed ID: 32860505
    [No Abstract]   [Full Text] [Related]  

  • 3. [2020 ESC guidelines on atrial fibrillation : Summary of the most relevant recommendations and innovations].
    Sepehri Shamloo A; Dagres N; Hindricks G
    Herz; 2021 Feb; 46(1):28-37. PubMed ID: 33289046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation.
    Camm AJ; Pinto FJ; Hankey GJ; Andreotti F; Hobbs FD;
    Europace; 2015 Jul; 17(7):1007-17. PubMed ID: 26116685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
    Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener HC; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P; Agewall S; Camm J; Baron Esquivias G; Budts W; Carerj S; Casselman F; Coca A; De Caterina R; Deftereos S; Dobrev D; Ferro JM; Filippatos G; Fitzsimons D; Gorenek B; Guenoun M; Hohnloser SH; Kolh P; Lip GY; Manolis A; McMurray J; Ponikowski P; Rosenhek R; Ruschitzka F; Savelieva I; Sharma S; Suwalski P; Tamargo JL; Taylor CJ; Van Gelder IC; Voors AA; Windecker S; Zamorano JL; Zeppenfeld K
    Europace; 2016 Nov; 18(11):1609-1678. PubMed ID: 27567465
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF).
    Kirchhof P; Ammentorp B; Darius H; De Caterina R; Le Heuzey JY; Schilling RJ; Schmitt J; Zamorano JL
    Europace; 2014 Jan; 16(1):6-14. PubMed ID: 24084680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
    Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
    Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
    Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener HC; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P; Agewall S; Camm J; Baron Esquivias G; Budts W; Carerj S; Casselman F; Coca A; De Caterina R; Deftereos S; Dobrev D; Ferro JM; Filippatos G; Fitzsimons D; Gorenek B; Guenoun M; Hohnloser SH; Kolh P; Lip GY; Manolis A; McMurray J; Ponikowski P; Rosenhek R; Ruschitzka F; Savelieva I; Sharma S; Suwalski P; Tamargo JL; Taylor CJ; Van Gelder IC; Voors AA; Windecker S; Zamorano JL; Zeppenfeld K
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):e1-e88. PubMed ID: 27663299
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
    Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
    Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey.
    Larsen TB; Potpara T; Dagres N; Proclemer A; Sciarrafia E; Blomström-Lundqvist C;
    Europace; 2015 May; 17(5):819-24. PubMed ID: 25926476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Consensus statement: Management of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation].
    Helms TM; Silber S; Schäfer A; Masuhr F; Palm F; Darius H; Schrör K; Bänsch D; Bramlage P; Hankowitz J; Karle CA; Stargardt T; Weil J; Geller JC
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):295-306. PubMed ID: 27576696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.
    Freeman JV; Shrader P; Pieper KS; Allen LA; Chan PS; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel JA; Singer DE; Go AS; Hylek EM; Steinberg BA; Peterson ED; Piccini JP
    Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007612. PubMed ID: 31830822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "As Needed" nonvitamin K antagonist oral anticoagulants for infrequent atrial fibrillation episodes following atrial fibrillation ablation guided by diligent pulse monitoring: A feasibility study.
    Zado ES; Pammer M; Parham T; Lin D; Frankel DS; Dixit S; Marchlinski FE
    J Cardiovasc Electrophysiol; 2019 May; 30(5):631-638. PubMed ID: 30706975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
    Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener HC; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P;
    Eur Heart J; 2016 Oct; 37(38):2893-2962. PubMed ID: 27567408
    [No Abstract]   [Full Text] [Related]  

  • 17. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey.
    Sabouret P; Bricard M; Hermann MA; Cotté FE; Deret-Bixio L; Rushton-Smith S
    Arch Cardiovasc Dis; 2015 Nov; 108(11):544-53. PubMed ID: 26113478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care.
    Hobbs FR; Taylor CJ; Jan Geersing G; Rutten FH; Brouwer JR;
    Eur J Prev Cardiol; 2016 Mar; 23(5):460-73. PubMed ID: 25701017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation.
    Chiang CE; Wu TJ; Ueng KC; Chao TF; Chang KC; Wang CC; Lin YJ; Yin WH; Kuo JY; Lin WS; Tsai CT; Liu YB; Lee KT; Lin LJ; Lin LY; Wang KL; Chen YJ; Chen MC; Cheng CC; Wen MS; Chen WJ; Chen JH; Lai WT; Chiou CW; Lin JL; Yeh SJ; Chen SA
    J Formos Med Assoc; 2016 Nov; 115(11):893-952. PubMed ID: 27890386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.